Abbott Laboratories Stock Options Expiring on 20th of June

ABT Stock  USD 127.21  0.87  0.69%   
Abbott Laboratories' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.4 with a put-to-call open interest ratio of 1.14 over 52 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on June 20th 2025. The total put volume is at 136, with calls trading at the volume of 138. This yields a 0.99 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

Abbott Laboratories option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Abbott Laboratories' lending market. For example, when Abbott Laboratories' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Abbott Laboratories, he or she must hedge the risk by shorting Abbott Laboratories stock over its option's life.
The chart above shows Abbott Laboratories' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Abbott Laboratories' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Abbott Laboratories' option, there is no secondary market available for investors to trade.

Abbott Laboratories Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain occurs when Abbott Laboratories' market makers reach a net positive position across all Abbott Laboratories' options at a strike price where option holders stand to lose the most money. By contrast, Abbott Laboratories' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

Abbott Laboratories In The Money Call Balance

When Abbott Laboratories' strike price is surpassing the current stock price, the option contract against Abbott Laboratories stock is said to be in the money. When it comes to buying Abbott Laboratories' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Abbott Laboratories are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Abbott Current Options Market Mood

Abbott Laboratories' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Abbott Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Abbott Laboratories' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Abbott Laboratories' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Abbott contract

Base on the Rule 16, the options market is currently suggesting that Abbott Laboratories will have an average daily up or down price movement of about 0.025% per day over the life of the 2025-06-20 option contract. With Abbott Laboratories trading at USD 127.21, that is roughly USD 0.0318. If you think that the market is fully incorporating Abbott Laboratories' daily price movement you should consider buying Abbott Laboratories options at the current volatility level of 0.4%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Abbott Laboratories Option Chain

When Abbott Laboratories' strike price is surpassing the current stock price, the option contract against Abbott Laboratories stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Abbott Laboratories' option chain is a display of a range of information that helps investors for ways to trade options on Abbott. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Abbott. It also shows strike prices and maturity days for a Abbott Laboratories against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
ABT250620C001800002180.00.0 - 1.930.11Out
Call
ABT250620C001750000175.00.0 - 2.160.14Out
Call
ABT250620C001700005170.00.0 - 2.170.19Out
Call
ABT250620C001650003165.00.0 - 2.00.38Out
Call
ABT250620C00160000257160.00.0 - 1.910.15Out
Call
ABT250620C00155000101155.00.0 - 1.910.25Out
Call
ABT250620C00150000536150.00.2 - 0.440.33Out
Call
ABT250620C001450002399145.00.48 - 1.960.6Out
Call
ABT250620C001400001670140.01.12 - 1.341.22Out
Call
ABT250620C001350001496135.02.28 - 2.492.32Out
Call
ABT250620C001300001471130.04.05 - 6.054.25Out
Call
ABT250620C001250001888125.06.55 - 7.556.45In
Call
ABT250620C001200002056120.09.6 - 10.1511.0In
Call
ABT250620C001150001230115.013.35 - 14.915.13In
Call
ABT250620C00110000912110.017.7 - 18.318.46In
Call
ABT250620C00105000973105.022.15 - 23.7523.3In
Call
ABT250620C00100000120100.026.75 - 28.5527.88In
Call
ABT250620C000975002997.528.95 - 31.0538.28In
Call
ABT250620C0009500012295.031.4 - 33.437.0In
Call
ABT250620C0009000018690.036.35 - 37.6541.3In
Call
ABT250620C000850002185.041.15 - 42.8545.1In
Call
ABT250620C000800004780.045.65 - 48.0533.5In
Call
ABT250620C00075000375.051.0 - 53.045.1In
Call
ABT250620C00070000470.056.0 - 57.6540.87In
Call
ABT250620C000550001555.070.6 - 72.779.94In
 Put
ABT250620P001800000180.052.45 - 54.3552.45In
 Put
ABT250620P001750000175.047.45 - 49.547.45In
 Put
ABT250620P001700000170.043.2 - 44.943.2In
 Put
ABT250620P001650000165.038.2 - 40.2538.2In
 Put
ABT250620P001600001160.032.8 - 34.622.8In
 Put
ABT250620P001550002155.027.55 - 29.815.5In
 Put
ABT250620P0015000013150.023.75 - 24.4512.1In
 Put
ABT250620P001450008145.018.7 - 19.5518.05In
 Put
ABT250620P00140000147140.013.9 - 15.713.5In
 Put
ABT250620P00135000389135.09.4 - 11.811.17In
 Put
ABT250620P00130000780130.06.9 - 7.57.3In
 Put
ABT250620P001250001796125.04.0 - 4.94.7Out
 Put
ABT250620P001200002131120.02.69 - 3.72.82Out
 Put
ABT250620P00115000813115.01.55 - 1.921.8Out
 Put
ABT250620P001100001575110.00.91 - 2.321.05Out
 Put
ABT250620P001050002310105.00.6 - 1.710.65Out
 Put
ABT250620P001000001680100.00.22 - 2.220.44Out
 Put
ABT250620P00097500139097.50.0 - 2.480.32Out
 Put
ABT250620P0009500045195.00.05 - 0.750.3Out
 Put
ABT250620P00090000193290.00.0 - 2.360.19Out
 Put
ABT250620P0008500025385.00.0 - 0.620.13Out
 Put
ABT250620P00080000116680.00.0 - 0.560.14Out
 Put
ABT250620P0007500017275.00.05 - 2.240.19Out
 Put
ABT250620P000700003570.00.0 - 1.150.08Out
 Put
ABT250620P00065000365.00.0 - 2.190.32Out
 Put
ABT250620P00060000260.00.0 - 2.170.82Out
 Put
ABT250620P0005500062755.00.0 - 2.160.2Out

Abbott Laboratories Market Cap Over Time

   Market Cap   
       Timeline  

Abbott Total Stockholder Equity

Total Stockholder Equity

50.05 Billion

At this time, Abbott Laboratories' Total Stockholder Equity is comparatively stable compared to the past year.

Abbott Laboratories Corporate Directors

Samuel ScottIndependent DirectorProfile
Phebe NovakovicIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile
Sally BlountIndependent DirectorProfile

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.